NCT05962606 2026-03-18Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.Aptarion Biotech AGPhase 2 Completed150 enrolled
NCT04673175 2026-01-21Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell TransplantationWeill Medical College of Cornell UniversityPhase 4 Terminated17 enrolled 20 charts